M. Tatemichi et al., DIFFERENCES IN HEMOSTASIS AMONG SCLEROSING AGENTS IN ENDOSCOPIC INJECTION SCLEROTHERAPY, Digestive diseases and sciences, 41(3), 1996, pp. 562-570
Endoscopic injection sclerotherapy is useful in stopping bleeding from
esophageal varices, We compared the in vivo effects of sclerosants on
thrombogenesis, hemostasis, and endothelial injury, We injected aetho
xysclerol (AS) or ethanolamine oleate (EO) into the small veins of the
rat intestine, The maximum thrombogenic index with AS was 30.7 and wi
th EO was 9.2, The venous flow stopped sooner with EO than with AS, Th
e thrombi caused by EO were mixed with red blood cells, Heparin pretre
atment decreased the thrombogenic index with AS by 96.7%, but not that
with EO. The area of the fluorescein-albumin conjugate that permeated
from veins with AS was larger than that with EO, The fluorescent inte
nsity with AS was lower than that with EO, We thus concluded that: (1)
the size of thrombi is not necessarily proportional to the hemostatic
efficacy: (2) changes in a patient's coagulation may affect the poten
tial of sclerosants: (3) the excellent hemostatic efficacy of EO is ba
sed on localized injury to the endothelium and the involvement of red
blood cells aggregation; and(4) in vivo microscopy is useful in determ
ining the rational selection of sclerosants.